Journal of Clinical Endocrinology & Metabolism, Vol 76, 156-161, Copyright © 1993 by Endocrine Society

ARTICLES

Endothelin binding to receptors and endothelin production by human thyroid follicular cells: effects of transforming growth factor-beta and thyrotropin

YC Tseng, S Lahiri, S Jackson, KD Burman and L Wartofsky
Department of Clinical Investigation and Medicine, Walter Reed Army Medical Center, Washington, DC 20307-5001.

Measurable endothelin (ET) was found in serum-free medium of cultured primary thyroid cells derived from human thyroid tissues after 3 days incubation at levels ranging from undetectable to 35 fmol/100,000 cells. Out of 12 thyroid glands studied, 2 responded to transforming growth factor-beta (TGF-beta) treatment with increased ET secretion into medium. Detailed study of cells derived from one of these thyroids showed TGF-beta at 1 ng/ml stimulated ET secretion from 13.7 to 33.3 fmol/100,000 cells after 3 days incubation. Although TSH alone did not significantly modulate ET release into medium, TSH enhanced the stimulatory effect of TGF-beta. A combination of TSH at 1 mU/ml and TGF- beta at 1 ng/ml stimulated ET secretion to 63.8 fmol/100,000 cells after 3 days incubation. Immunostaining studies demonstrated the presence of intracellular immunoreactive ET, largely localized in perinuclear regions, which was greatly stimulated by TSH but not by TGF- beta. These observations suggest that TSH may stimulate only ET synthesis, whereas TGF-beta may stimulate both synthesis and secretion. Binding of [125I]ET-1 to receptor on thyroid cells was dose-dependently stimulated by TGF-beta (0-10 ng/ml) pretreatment for 3 days. Scatchard analysis of competitive binding data from TGF-beta (1 ng/ml)-treated cells indicated that increased binding was the result of increased receptor number and not increased receptor affinity. TSH (0-10 mU/ml), though not as potent as TGF-beta, also dose-dependently stimulated ET binding. Treatment of thyrocytes with 1 mU/ml TSH for 3 days did not significantly affect ET receptor number or binding affinity. These results illuminate aspects of a possible autocrine regulation of ET in the thyroid gland.

This article has been cited by other articles:

				C.-H. Chu, J.-K. Lee, H.-M. Keng, M.-J. Chuang, C.-C. Lu, M.-C. Wang, C.-C. Sun, M.-C. Wei, and H.-C. Lam Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Experimental Biology and Medicine, June 1, 2006; 231(6): 1040 - 1043. [Abstract] [Full Text] [PDF]

				T. Tamada, T. Sasaki, H. Saitoh, Y. Ohkawara, T. Irokawa, K. Sasamori, T. Oshiro, G. Tamura, S. Shimura, and K. Shirato A Novel Function of Thyrotropin as a Potentiator of Electrolyte Secretion from the Tracheal Gland Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 566 - 573. [Abstract] [Full Text]

				G. Napolitano, V. Montani, C. Giuliani, S. Di Vincenzo, I. Bucci, V. Todisco, G. Laglia, A. Coppa, D. S. Singer, M. Nakazato, et al. Transforming Growth Factor-{beta}1 Down-Regulation of Major Histocompatibility Complex Class I in Thyrocytes: Coordinate Regulation Of Two Separate Elements by Thyroid-Specific as Well as Ubiquitous Transcription Factors Mol. Endocrinol., April 1, 2000; 14(4): 486 - 505. [Abstract] [Full Text]